(Q34510718)

2 August 2017

1 reference

title

Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark? (English)

1 reference

2 August 2017

John A Mengshol

1

1 reference

2 August 2017

Kimberlee S Mix

series ordinal

2

1 reference

2 August 2017

Constance E Brinckerhoff

series ordinal

3

1 reference

2 August 2017

publication date

1 January 2002

1 reference

2 August 2017

published in

Arthritis & Rheumatology

1 reference

2 August 2017

volume

46

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

13-20

1 reference

Matrix metalloproteinases: multifunctional contributors to tumor progression

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

In situ zymographic localisation of type II collagen degrading activity in osteoarthritic human articular cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Interaction of alpha 2-macroglobulin with matrix metalloproteinases and its use for identification of their active forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Matrix metalloproteinases: biologic activity and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Ongoing trials with matrix metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Thirty-six years in the clinic without an MMP inhibitor. What hath collagenase wrought?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Matrix metalloproteinase inhibition. From the Jurassic to the third millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Signal transduction and transcription factors in rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Studies on the contribution of c-fos/AP-1 to arthritic joint destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

NF-kappaB: a key role in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Biochemical characterization of human collagenase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Cell migration through extracellular matrix: membrane-type metalloproteinases make the way

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200201%2946%3A1%3C13%3A%3AAID-ART497%3E3.0.CO%3B2-S

10.1002/1529-0131(200201)46:1<13::AID-ART497>3.0.CO;2-S

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference